Tevogen Bio Holdings INC 8-K filings

Semper Paratus Acquisition Corporation shareholders have approved the proposed business combination with Tevogen Bio, paving the way for the merger to be completed.

Semper Paratus Acquisition Corporation has filed a supplement to its proxy statement, announcing the planned listing of Tevogen Bio Holdings Inc. on the Nasdaq Stock Market instead of the NYSE American.